• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER NEUROVASCULAR-UTAH-SALT LAKE CITY TREVO XP PROVUE 3MM X 20MM; CATHETER, THROMBUS RETRIEVER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER NEUROVASCULAR-UTAH-SALT LAKE CITY TREVO XP PROVUE 3MM X 20MM; CATHETER, THROMBUS RETRIEVER Back to Search Results
Catalog Number 90183
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Appropriate Term/Code Not Available (3191)
Patient Problems Hemorrhage/Bleeding (1888); High Blood Pressure/ Hypertension (1908); Paralysis (1997); Pneumonia (2011); Dysphasia (2195); Loss of consciousness (2418); Ischemia Stroke (4418); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/19/2021
Event Type  Injury  
Manufacturer Narrative
Device evaluated by mfr: the subject device is unavailable to manufacturer.
 
Event Description
It was reported that the patient with no specified medical history, had been received the experimental procedure (mechanical thrombectomy) on (b)(6) 2021 (randomization in experimental arm).On (b)(6) 2021, the patient experienced a neurological status deterioration: malignant sylvian infarction (edema and mass effect on early post-thrombectomy ct scan) associated with impaired alertness.) and a craniectomy was performed to treat the event.The patient experienced a life-threatening event.The patient was recovering from neurological status deterioration and was discharged to continuing care.No other information was provided.
 
Manufacturer Narrative
Section b5 - executive summary: update.Section d- lot # :corrected - lot # has been corrected from unknown to 40362971.Section f10/h6 clinical signs code grid: updated - hemorrhage/bleeding has been added.
 
Event Description
It was reported that the patient with no specified medical history, had been received the experimental procedure (mechanical thrombectomy) on (b)(6) 2021 (randomization in experimental arm).On (b)(6) 2021, the patient experienced a neurological status deterioration: malignant sylvian infarction (edema and mass effect on early post-thrombectomy ct scan) associated with impaired alertness.) and a craniectomy was performed to treat the event.The patient experienced a life-threatening event.The patient was recovering from neurological status deterioration and was discharged to continuing care.No other information was provided.Update information: received additional information on 27-december-2021 stated that at the patient's 3-month follow-up, a blinded assessment of the mrs (modified rankin score) was performed by telephone on (b)(6) 2021.The current mrs is 3.Per physician¿s opinion, the subject trevo device performed as intended and there was no allegation against the subject trevo device.
 
Manufacturer Narrative
Section f10/h6 clinical signs code grid: corrected - ischemia stroke and high blood pressure/ hypertension have been removed.Added: paralysis , dysphasia, and pneumonia.
 
Event Description
It was reported that the patient with no specified medical history, had been received the experimental procedure (mechanical thrombectomy) on (b)(6) 2021 (randomization in experimental arm).On (b)(6) 2021, the patient experienced a neurological status deterioration: malignant sylvian infarction (edema and mass effect on early post-thrombectomy ct scan) associated with impaired alertness.) and a craniectomy was performed to treat the event.The patient experienced a life-threatening event.The patient was recovering from neurological status deterioration and was discharged to continuing care.No other information was provided.Update information: received additional information on 27-december-2021 stated that at the patient's 3-month follow-up, a blinded assessment of the mrs (modified rankin score) was performed by telephone on (b)(6) 2021.The current mrs is 3.Per physician¿s opinion, the subject trevo device performed as intended and there was no allegation against the subject trevo device.
 
Manufacturer Narrative
It was confirmed that the same reported event, product had already been entered and captured under (b)(4).Based on this update, this record ((b)(4)) along with associated children will be cancelled due this duplicate entry.Refer to (b)(4) for the continuation of the complaint process of the alleged issue associated with the subject complaint device.Therefore, this event does not meet the criteria of a complaint and will be canceled.B1 product problem: corrected: no adverse event.B2 outcomes attributed to ae : corrected : no outcomes attributed to ae.B5 executive summary: updated.H1 type of reportable event: corrected : no serious injury.Device code grid : corrected: no 'adverse event without identified device or use problem' f10 / h6 health effect - clinical code/ health effect - impact code: corrected to 'no health consequences or impact; and 'no clinical signs, symptoms or conditions'.
 
Event Description
It was reported that the patient with no specified medical history, had been received the experimental procedure (mechanical thrombectomy) on (b)(6) 2021 (randomization in experimental arm).On (b)(6) 2021, the patient experienced a neurological status deterioration: malignant sylvian infarction (edema and mass effect on early post-thrombectomy ct scan) associated with impaired alertness.) and a craniectomy was performed to treat the event.The patient experienced a life-threatening event.The patient was recovering from neurological status deterioration and was discharged to continuing care.No other information was provided.Update information: received additional information on 27-december-2021 stated that at the patient's 3-month follow-up, a blinded assessment of the mrs (modified rankin score) was performed by telephone on 21/10/2021.The current mrs is 3.Per physician¿s opinion, the subject trevo device performed as intended and there was no allegation against the subject trevo device.2nd update information: it was confirmed that the same reported event, product had already been entered and captured under pi# (b)(4).Based on this update, this record ((b)(4)) along with associated children will be cancelled due this duplicate entry.Refer to pi# (b)(4) for the continuation of the complaint process of the alleged issue associated with the subject complaint device.Therefore, this event does not meet the criteria of a complaint and will be canceled.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TREVO XP PROVUE 3MM X 20MM
Type of Device
CATHETER, THROMBUS RETRIEVER
Manufacturer (Section D)
STRYKER NEUROVASCULAR-UTAH-SALT LAKE CITY
4870 west 2100 south
salt lake city UT 84120
Manufacturer (Section G)
STRYKER NEUROVASCULAR-UTAH-SALT LAKE CITY
4870 west 2100 south
salt lake city UT 84120
Manufacturer Contact
tara lopez
47900 bayside parkway
fremont, CA 94538
5104132500
MDR Report Key12760288
MDR Text Key280443114
Report Number3012931345-2021-00182
Device Sequence Number1
Product Code NRY
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K133464
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Pharmacist
Type of Report Initial,Followup,Followup,Followup
Report Date 02/10/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/07/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number90183
Device Lot Number40362971
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/03/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
SOFIA 5 (MICROVENTION).; SOFIA 6 (MICROVENTION).
Patient Outcome(s) Other; Life Threatening; Required Intervention; Hospitalization;
Patient Age51 YR
Patient SexMale
-
-